Media OutReach
Prudential launches indexed universal life plan to meet demand for flexible legacy planning solutions
PRUApex Legacy Index II gives affluent and high-net-worth individuals greater flexibility to build, protect and transfer wealth to the next generation with premium allocation across multiple indices including a gold-equity index; it offers flexible payout options and choice of premium terms
SINGAPORE – Media OutReach Newswire – 20 July 2026 – Prudential Singapore (“Prudential”) has launched PRUApex Legacy Index II, an indexed universal life plan (IUL) designed for affluent and high-net-worth customers seeking more options to grow and preserve their legacy and structure wealth transfer for the next generation.
Customers can customise how their legacy grows and is passed on, with multiple index allocations, death benefit payout structures, and premium terms. They are also supported by an additional crediting rate of 0.25% p.a. for indices with uncapped returns[1] (i.e. volatility-controlled indices), and a one-time bonus crediting rate of up to 6.50%[2] on total account value after the end of premium term for a fully paid policy on multipay premium payment term.
Ms Toni Fung, Chief Customer and Marketing Officer, Prudential Singapore, said: “Affluent and high-net-worth individuals are increasingly looking for legacy planning solutions that will evolve with their changing life priorities, giving them greater certainty, control and confidence over how their legacy is passed on to the next generation. Today, when they want to make any changes, it means having to purchase new policies or restructure existing portfolios. PRUApex Legacy Index II addresses this need for flexibility, allowing customers to build a resilient legacy through diversified growth potential across multiple indices. It also helps to future-proof their plans with flexible death benefit payout structures.”
Diversified growth potential across markets and asset classes
PRUApex Legacy Index II allows customers to diversify and allocate premiums across a mix of indices, offering broader market exposure across the United States (US), Europe, and emerging markets (e.g. China, South Korea and Brazil), as well as a gold-equity index. They have access to indices with both capped and uncapped returns (i.e. volatility-controlled indices that have no cap on potential gains[1]) that meet their legacy planning needs, and the flexibility to balance stability and growth potential based on their risk appetite.
Ms Fung added: “We were the first insurer in Singapore to introduce a volatility-controlled index (i.e. index with uncapped returns[1]) in an indexed universal life plan two years ago. With PRUApex Legacy Index II, we are expanding the range of index options available to customers, giving them more ways to grow and protect their legacy through familiar indices with capped returns, such as the S&P 500, and indices that provide higher stability through their volatility-controlled design while offering uncapped return[1] potential.”
Customers who prefer a standard market index can opt for indices such as the S&P 500[3][8], MSCI Emerging Markets[3][8], and EURO STOXX 50[3][8]. If they are looking for indices with uncapped returns[1] that provide a stable, pre-determined level of risk, they can choose from volatility-controlled indices including the S&P 500 FC[4][8], UBS MASTR[5][8], Barclays Shiller Allocator[6][8] and MSCI World Golden Compass[7][8].
Future-proofing legacy planning with flexible design
PRUApex Legacy Index II gives policyholders more flexibility over how death benefits are paid out. Instead of receiving the full amount as a single lump sum, beneficiaries can receive payouts in one lump sum, or in yearly instalments of 2 to 10 years to provide continued support for their loved ones.
Customers can choose from single-premium and multipay options for up to 20 years. This gives them more choices based on their liquidity needs, legacy planning priorities, and preferred pace of premium commitment.
For the Fixed Account, there is a first-year Crediting Rate of 4.20% p.a. & Guaranteed Minimum Crediting Rate of 2.00% p.a.
Affluent and high-net-worth customers can kickstart their legacy planning with PRUApex Legacy Index II with a sum assured as low as US$500,000.
For more information on PRUApex Legacy Index II, please visit: https://www.prudential.com.sg/products/legacy-planning/pruapex-legacy-index-ii
Hashtag: #PrudentialSingapore #Prudential #PRUApexLegacyIndexII #Product #Insurance #LegacyPlanning #Affluent #HNW
https://www.prudential.com.sg/
https://www.linkedin.com/company/prudential-assurance-company-singapore
https://www.facebook.com/PrudentialSingapore/
https://www.instagram.com/prudentialsingapore/
The issuer is solely responsible for the content of this announcement.
About Prudential Assurance Company Singapore (Pte) Ltd (Prudential Singapore)
Prudential Assurance Company Singapore (Pte) Ltd is one of the top life and health insurance companies in Singapore, serving the financial and protection needs of the country’s citizens for 95 years. As at 31 December 2025, it has S$66.3 billion funds under management. The company has an AA Financial Strength Rating from leading credit rating agency Standard & Poor’s and delivers a suite of well-rounded product offerings in Protection, Savings and Investment through multiple distribution channels including a network of 5,400 financial representatives.
Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.
ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.
In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.
Acquisitions Support Service Network Expansion
ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.
In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.
By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.
Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.
The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.
Hashtag: #ZenaTech
The issuer is solely responsible for the content of this announcement.
About ZenaTech
ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.
Media OutReach
A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04
Hashtag: #SPOTMAS
https://spotmas.com.hk/The issuer is solely responsible for the content of this announcement.
Media OutReach
St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys
Overview of the WACE Curriculum at SFMS
SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.
SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.
Academic Outcomes and University Placements
In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.
In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.
Student Journeys and Holistic Development
Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.
Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.
Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.
These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational
https://www.sfms.edu.sg/
https://www.facebook.com/sfms.singapore
https://www.instagram.com/sfms_sg/
https://www.youtube.com/channel/UC_bb9hcNhAk7WgYBE_FI61A/featured
The issuer is solely responsible for the content of this announcement.
About St Francis Methodist School International
Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.
